Parallel Advisors, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$100,449
+74.6%
2,306
+44.8%
0.00%
+50.0%
Q2 2023$57,519
+9.5%
1,592
+12.7%
0.00%0.0%
Q1 2023$52,535
-30.6%
1,413
-15.4%
0.00%
-33.3%
Q4 2022$75,668
-4.2%
1,670
+48.6%
0.00%
-25.0%
Q3 2022$79,000
+21.5%
1,124
+15.5%
0.00%
+33.3%
Q2 2022$65,000
+109.7%
973
+162.3%
0.00%
+200.0%
Q1 2022$31,000
+138.5%
371
+307.7%
0.00%
Q4 2021$13,000
+160.0%
91
+250.0%
0.00%
Q3 2021$5,000
+400.0%
26
+420.0%
0.00%
Q2 2021$1,000
-75.0%
5
-78.3%
0.00%
Q1 2021$4,0000.0%23
+21.1%
0.00%
Q4 2020$4,000
+300.0%
19
+216.7%
0.00%
Q3 2020$1,00060.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders